{"database": "lobbying", "table": "lobbying_activities", "rows": [[1106703, "23f806f6-1779-4fd2-a454-baef7910a4c3", "Q2", "LAW OFFICES OF MARC SHAPIRO", 400761290, "POZEN INC.", 2011, "second_quarter", "MED", "Amendment of new drug approval provisions of Federal Food, Drug and Cosmetic Act; no bill pending", "HOUSE OF REPRESENTATIVES", 20000, null, 0, 0, "2011-06-27T14:39:20.957000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1106703"], "units": {}, "query_ms": 42.151281028054655, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}